These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 36539841)
1. Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study. Erfaninejad M; Salahshouri A; Amirrajab N Eur J Med Res; 2022 Dec; 27(1):303. PubMed ID: 36539841 [TBL] [Abstract][Full Text] [Related]
3. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis. Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D Front Immunol; 2022; 13():959740. PubMed ID: 35967437 [TBL] [Abstract][Full Text] [Related]
4. Exploring Iranian β-Thalassemia major patients' perception of barriers and facilitators of adherence to treatment: A qualitative study. Emami Zeydi A; Karimi Moonaghi H; Heydari A Electron Physician; 2017 Dec; 9(12):6102-6110. PubMed ID: 29560166 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Watson C; Calabretto H Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):262-72. PubMed ID: 17627679 [TBL] [Abstract][Full Text] [Related]
7. The Relationship Between Vulvovaginal Candidiasis and Provoked Vulvodynia: A Systematic Review. Leusink P; van de Pasch S; Teunissen D; Laan ET; Lagro-Janssen AL J Sex Med; 2018 Sep; 15(9):1310-1321. PubMed ID: 30145093 [TBL] [Abstract][Full Text] [Related]
8. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Nyirjesy P; Brookhart C; Lazenby G; Schwebke J; Sobel JD Clin Infect Dis; 2022 Apr; 74(Suppl_2):S162-S168. PubMed ID: 35416967 [TBL] [Abstract][Full Text] [Related]
10. Vulvovaginal candidiasis: An overview of mycological, clinical, and immunological aspects. Jafarzadeh L; Ranjbar M; Nazari T; Naeimi Eshkaleti M; Aghaei Gharehbolagh S; Sobel JD; Mahmoudi S J Obstet Gynaecol Res; 2022 Jul; 48(7):1546-1560. PubMed ID: 35445492 [TBL] [Abstract][Full Text] [Related]
11. Recurrent vulvovaginal candidiasis: A review of guideline recommendations. Matheson A; Mazza D Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):139-145. PubMed ID: 28299777 [TBL] [Abstract][Full Text] [Related]
12. Exploring the barriers of adherence to dietary recommendations among patients with type 2 diabetes: A qualitative study in Iran. Mostafavi-Darani F; Zamani-Alavijeh F; Mahaki B; Salahshouri A Nurs Open; 2020 Nov; 7(6):1735-1745. PubMed ID: 33072357 [TBL] [Abstract][Full Text] [Related]
13. Recurrent vulvovaginal candidiasis - current management. Watson C; Pirotta M Aust Fam Physician; 2011 Mar; 40(3):149-51. PubMed ID: 21597520 [TBL] [Abstract][Full Text] [Related]
14. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis. Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275 [TBL] [Abstract][Full Text] [Related]